1,3-ditolylguanidine has been researched along with Cancer of Pancreas in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abate, C; Berardi, F; Hawkins, WG; Hornick, JR; Niso, M; Perrone, R; Spitzer, D | 1 |
1 other study(ies) available for 1,3-ditolylguanidine and Cancer of Pancreas
Article | Year |
---|---|
Fluorescent derivatives of σ receptor ligand 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28) as a tool for uptake and cellular localization studies in pancreatic tumor cells.
Topics: Binding, Competitive; Cell Line, Tumor; Endocytosis; Endoplasmic Reticulum; Flow Cytometry; Fluorescence; Humans; Ligands; Lysosomes; Microscopy, Confocal; Microscopy, Fluorescence; Models, Chemical; Molecular Structure; Pancreatic Neoplasms; Piperazines; Protein Binding; Protein Isoforms; Radioligand Assay; Receptors, sigma | 2011 |